Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

March 31, 2015

Conditions
Neoplasms, Breast
Interventions
DRUG

pazopanib (GW786034) 400 mg

400 mg administered orally once daily

DRUG

lapatinib (GW572016) 1500 mg

1500 mg administered orally once daily.

DRUG

lapatinib (GW572016) 1000 mg

1000 mg administered orally once daily

DRUG

pazopanib (GW786034) 800 mg

800 mg administered orally once daily

Trial Locations (84)

1082

GSK Investigational Site, Budapest

1122

GSK Investigational Site, Budapest

1590

GSK Investigational Site, Islamabad

10330

GSK Investigational Site, Bangkok

10461

GSK Investigational Site, The Bronx

13273

GSK Investigational Site, Marseille Cedex BP 156

25030

GSK Investigational Site, Besançon

31096

GSK Investigational Site, Haifa

44304

GSK Investigational Site, Akron

46202

GSK Investigational Site, Indianapolis

47400

GSK Investigational Site, Petaling Jaya

49100

GSK Investigational Site, Petah Tikva

52621

GSK Investigational Site, Ramat Gan

54000

GSK Investigational Site, Lahore

54600

GSK Investigational Site, Lahore

59020

GSK Investigational Site, Lille

59100

GSK Investigational Site, Bandar Tun Razak, Cheras

60000

GSK Investigational Site, Multan

64239

GSK Investigational Site, Tel Aviv

67000

GSK Investigational Site, Strasbourg

69437

GSK Investigational Site, Lyon

70006

GSK Investigational Site, Metairie

72401

GSK Investigational Site, Jonesboro

74800

GSK Investigational Site, Karachi

75248

GSK Investigational Site, Paris

76100

GSK Investigational Site, Rehovot

78207

GSK Investigational Site, San Antonio

79410

GSK Investigational Site, Lubbock

83400

GSK Investigational Site, Hyères

89052

GSK Investigational Site, Henderson

90277

GSK Investigational Site, Redondo Beach

90813

GSK Investigational Site, Long Beach

91031

GSK Investigational Site, Jerusalem

91328

GSK Investigational Site, Northridge

91801

GSK Investigational Site, Alhambra

92835

GSK Investigational Site, Fullerton

93030

GSK Investigational Site, Oxnard

93105

GSK Investigational Site, Santa Barbara

93309

GSK Investigational Site, Bakersfield

93454

GSK Investigational Site, Santa Maria

97500

GSK Investigational Site, Mérida

110085

GSK Investigational Site, Delhi

117997

GSK Investigational Site, Moscow

129128

GSK Investigational Site, Moscow

169610

GSK Investigational Site, Singapore

197022

GSK Investigational Site, Saint Petersburg

197758

GSK Investigational Site, Saint Petersburg

302004

GSK Investigational Site, Jaipur

400012

GSK Investigational Site, Mumbai

411001

GSK Investigational Site, Pune

560029

GSK Investigational Site, Bangalore

695011

GSK Investigational Site, Trivandrum

90095-1752

GSK Investigational Site, Los Angeles

75390-9113

GSK Investigational Site, Dallas

T6G 1Z2

GSK Investigational Site, Edmonton

B3H 1V7

GSK Investigational Site, Halifax

M9N 1N8

GSK Investigational Site, Weston

H-9024

GSK Investigational Site, Győr

411 004

GSK Investigational Site, Pune

CP 14080

GSK Investigational Site, Mexico City

Lima 11

GSK Investigational Site, Lima

Lima 34

GSK Investigational Site, Lima

Callao 2

GSK Investigational Site, Callao

82-300

GSK Investigational Site, Elblag

25-640

GSK Investigational Site, Kielce

31-108

GSK Investigational Site, Krakow

10-226

GSK Investigational Site, Olsztyn

10-228

GSK Investigational Site, Olsztyn

02-781

GSK Investigational Site, Warsaw

115 478

GSK Investigational Site, Moscow

400-711

GSK Investigational Site, Incheon

120-752

GSK Investigational Site, Seodaemun-gu, Seoul

138-736

GSK Investigational Site, Songpa-gu, Seoul

443-721

GSK Investigational Site, Suwon, Kyonggi-do

CM1 7ET

GSK Investigational Site, Chelmsford

M20 4BX

GSK Investigational Site, Manchester

SM2 5PT

GSK Investigational Site, Sutton

B15 2TH

GSK Investigational Site, Birmingham

G12 OYN

GSK Investigational Site, Glasgow

IP4 5PD

GSK Investigational Site, Ipswich

SE1 9RT

GSK Investigational Site, London

SW3 6JJ

GSK Investigational Site, London

NG5 1PB

GSK Investigational Site, Nottingham

PL6 8DH

GSK Investigational Site, Plymouth

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY